Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma

Clinical trial NCT00734890 · COMPLETED

Trial details

NCT number: NCT00734890
Sponsor: National Institutes of Health Clinical Center (CC)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer Lymphoma Lymphoproliferative Disorder Small Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2008-03-01
Primary completion: 2010-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.